Search Results 2061-2070 of 16843 for Maximum

  1. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

    ... maximum medical treatment. Stewart DJ. D J; Hilton JD. J D; Arnold JM. J M O; Gregoire J. J; Rivard A. A; Archer SL. S L; Charbonneau F. F; Cohen E. E ...

  2. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    ... maximum dimension =< 5 cm OR gross tumor volume < 20 cm^3. All relapsed disease would need to be eligible to be treated with reirradiation. Patients must ...

  3. Clinical Trial of Upfront Haploidentical or Unrelated Donor Bmt to Restore Normal Hematopoiesis in Aplastic Anemia

    Cell dose can be estimated using the following NMDP formula:[45] Estimated maximum donor volume2 x 0.183e8/mL = Estimated total nucleated cells;; ABO ...

  4. Oncology (Medical) - Clinical trials - Mayo Clinic

    The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + vinblastine for ...

  5. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

    Part 1 (monotherapy dose escalation) will evaluate safety and determine the maximum tolerated dose of INCB053914 monotherapy and the recommended phase 2 ...

  6. Clinical trials - Oncology (Medical)

    ... determine the maximum tolerated dose (MTD), identify a recommended phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity.

  7. Clinical trials - Oncology (Medical)

    ... determine the maximum tolerated dose (MTD), identify a recommended phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity.

  8. Clinical trials - Oncology (Medical)

    ... maximum) over a period of 12 months * Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 ...

  9. Study to Evaluate the Safety, Tolerability and Antitumor Activity of Anti-B7-H3 Car-T Cell Injection (TX103) in Subjects With Recurrent or Progressive Grade 4 Glioma - Mayo Clinic

    ... glioma. To determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) for intracranial infusion of Anti-B7-H3 CAR-T Cell Injection.

  10. A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma - Mayo Clinic

    Due to the timing of enrollment, patients who have completed a maximum of 16 weeks of 1st line chemotherapy may be enrolled >16 weeks after initiation of ...